Boston Scientific Corp
Close on Nov 18, 2026Market cap $63.24BP/E 17.7Yield –
Boston Scientific Trailing 12-Month (TTM) Adjusted EBITDA by Quarter
Trailing 12-Month (TTM) Adjusted EBITDA ($M) ($M)
Boston Scientific Trailing 12-Month (TTM) Adjusted EBITDA: $6,192M in Q3 2026, up 7.5% from a year earlier.
Where the Q3 2026 figure comes from
“Adjusted EBITDA $ 1,558 $ 1,540 $ 1,630 $ 1,464 $ 6,192”
Source: BSX FY2026Q3 Financial & Operational Highlights Presentation ↗
Reported in Quarterly FOH Appendix C.
quarterly history
Hover a value to see the sentence it was read from; calculated values show their formula
Cite this data
StockData. (2026). Boston Scientific Trailing 12-Month (TTM) Adjusted EBITDA ($M), quarterly Q1 2023–Q3 2026 [Data set]. Compiled from Boston Scientific SEC filings and investor materials. https://stockdatahq.com/stocks/bsx/kpis/lev-ttm-adj-ebitda
See every metric in the Boston Scientific KPI table. Data updated Nov 4, 2026.
See a number that looks wrong?